{
    "2019-04-08": [
        [
            {
                "time": "2023-10-05",
                "original_text": "Eye-Care Leader Alcon Is About to Hit the Stock Market",
                "features": {
                    "keywords": [
                        "Alcon",
                        "eye-care",
                        "stock market"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "none"
                }
            },
            {
                "time": "2023-10-05",
                "original_text": "Corcept (CORT) Rides High on Cushing's Syndrome Drug Korlym",
                "features": {
                    "keywords": [
                        "Corcept",
                        "Cushing's Syndrome",
                        "Korlym"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2023-10-05",
                "original_text": "The Zacks Analyst Blog Highlights: Pfizer, Teva, Novartis, Merck and AstraZeneca",
                "features": {
                    "keywords": [
                        "Zacks",
                        "Pfizer",
                        "Teva",
                        "Novartis",
                        "Merck",
                        "AstraZeneca"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "none",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2023-10-05",
                "original_text": "Lawsuit over migraine deal could be good for Amgen, analysts say",
                "features": {
                    "keywords": [
                        "lawsuit",
                        "migraine",
                        "Amgen"
                    ],
                    "sentiment_score": 0.5,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "biotechnology"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2023-10-05",
                "original_text": "Why Amgen's Giving Novartis a Headache",
                "features": {
                    "keywords": [
                        "Amgen",
                        "Novartis",
                        "headache"
                    ],
                    "sentiment_score": -0.4,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "biotechnology"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            }
        ]
    ]
}